000 02428 a2200673 4500
005 20250516005040.0
264 0 _c20101130
008 201011s 0 0 eng d
022 _a1474-547X
024 7 _a10.1016/S0140-6736(10)61384-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGane, Edward J
245 0 0 _aOral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.
_h[electronic resource]
260 _bLancet (London, England)
_cOct 2010
300 _a1467-75 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aCyclopropanes
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHepacivirus
_xgenetics
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aIsoindoles
650 0 4 _aLactams
_xadministration & dosage
650 0 4 _aLactams, Macrocyclic
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolyethylene Glycols
_xadministration & dosage
650 0 4 _aProline
_xanalogs & derivatives
650 0 4 _aRNA, Viral
_xblood
650 0 4 _aRecombinant Proteins
650 0 4 _aSulfonamides
_xadministration & dosage
650 0 4 _aViral Nonstructural Proteins
_xantagonists & inhibitors
700 1 _aRoberts, Stuart K
700 1 _aStedman, Catherine A M
700 1 _aAngus, Peter W
700 1 _aRitchie, Brett
700 1 _aElston, Rob
700 1 _aIpe, David
700 1 _aMorcos, Peter N
700 1 _aBaher, Linda
700 1 _aNajera, Isabel
700 1 _aChu, Tom
700 1 _aLopatin, Uri
700 1 _aBerrey, M Michelle
700 1 _aBradford, William
700 1 _aLaughlin, Mark
700 1 _aShulman, Nancy S
700 1 _aSmith, Patrick F
773 0 _tLancet (London, England)
_gvol. 376
_gno. 9751
_gp. 1467-75
856 4 0 _uhttps://doi.org/10.1016/S0140-6736(10)61384-0
_zAvailable from publisher's website
999 _c20254688
_d20254688